GPT and metabolic dysfunction-associated steatotic liver disease: These findings were confirmed by higher levels of serum markers of liver dysfunction such as aspartate aminotransferase (ALT), alanine aminotransferase (AST), γ-glutamyl transpeptidase (GGT), and high-sensitivity C-reactive protein (hs-CRP) in NAFLD patients affected by MDD [12].